Non-viral, precisely engineered immune cells tested in lymphoma

被引：0
|
作者：
Hu, Yongxian [1 ]
Zhang, Jiqin [2 ]
Eyquem, Justin [3 ]
机构：
[1] Zhejiang Univ, Sch Med, Hangzhou, Peoples R China
[2] East China Normal Univ, Shanghai, Peoples R China
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NATURE | 2022年
关键词：
Cancer; Therapeutics; Drug discovery;
D O I：
10.1038/d41586-022-02272-z
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
An improved approach has been developed for producing precisely designed immune cells called CAR T cells that recognize and kill cancer cells. CAR T cells generated in this way were safe and showed potential therapeutic effects in individuals with a relapsed or treatment-resistant form of the immune-cell cancer called B-cell non-Hodgkin's lymphoma.
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inorganic coatings for optimized non-viral transfection of stem cells
    Siyoung Choi
    Xiaohua Yu
    Leenaporn Jongpaiboonkit
    Scott J. Hollister
    William L. Murphy
    Scientific Reports, 3
  • [22] Inorganic coatings for optimized non-viral transfection of stem cells
    Choi, Siyoung
    Yu, Xiaohua
    Jongpaiboonkit, Leenaporn
    Hollister, Scott J.
    Murphy, William L.
    SCIENTIFIC REPORTS, 2013, 3
  • [23] The Past, Present, and Future of Non-Viral CAR T Cells
    Moretti, Alex
    Ponzo, Marianna
    Nicolette, Charles A.
    Tcherepanova, Irina Y.
    Biondi, Andrea
    Magnani, Chiara F.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Viral and non-viral risk factors for non-Hodgkin’s lymphoma in Egypt: heterogeneity by histological and immunological subtypes
    Lenka Goldman
    Sameera Ezzat
    Nadia Mokhtar
    Amany Abdel-Hamid
    Nathan Fowler
    Iman Gouda
    Soheir Abdel Latif Eissa
    Mohamed Abdel-Hamid
    Christopher A. Loffredo
    Cancer Causes & Control, 2009, 20 : 981 - 987
  • [25] Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes
    Goldman, Lenka
    Ezzat, Sameera
    Mokhtar, Nadia
    Abdel-Hamid, Amany
    Fowler, Nathan
    Gouda, Iman
    Eissa, Soheir Abdel Latif
    Abdel-Hamid, Mohamed
    Loffredo, Christopher A.
    CANCER CAUSES & CONTROL, 2009, 20 (06) : 981 - 987
  • [26] A Systemic Optimization of Non-Viral Engineering of Human B Cells
    Laoharawee, Kanut
    Johnson, Matthew
    Kleinboehl, Evan
    Jensen, Jacob
    Peterson, Joseph
    Lahr, Walker
    Webber, Beau
    Moriarity, Branden
    MOLECULAR THERAPY, 2022, 30 (04) : 271 - 271
  • [27] Non-viral carriers for optimal mRNA delivery in Hela cells
    Tavernier, Geertrui
    Rejman, Joanna
    De Smedt, Stefaan
    HUMAN GENE THERAPY, 2009, 20 (11) : 1518 - 1518
  • [28] Efficient and gentle non-viral engineering of therapeutic cells by photoporation
    Braeckmans, K.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A322 - A322
  • [29] New non-viral method for gene transfer into primary cells
    Gresch, O
    Engel, FB
    Nesic, D
    Tran, TT
    England, HM
    Hickman, ES
    Körner, I
    Gan, L
    Chen, S
    Castro-Obregon, S
    Hammermann, R
    Wolf, J
    Müller-Hartmann, H
    Nix, M
    Siebenkotten, G
    Kraus, G
    Lun, K
    METHODS, 2004, 33 (02) : 151 - 163
  • [30] Comparison of different non-viral integrating vectors in lung cells
    Rath, Sebastian
    Aneja, Manish
    Imker, Rabea
    Rudolph, Carsten
    HUMAN GENE THERAPY, 2009, 20 (11) : 1510 - 1511
12345